...
首页> 外文期刊>Recent patents on anti-cancer drug discovery >Modeling and Proposed Molecular Mechanism of Hydroxyurea Through Docking and Molecular Dynamic Simulation to Curtail the Action of Ribonucleotide Reductase
【24h】

Modeling and Proposed Molecular Mechanism of Hydroxyurea Through Docking and Molecular Dynamic Simulation to Curtail the Action of Ribonucleotide Reductase

机译:通过对接和分子动态模拟来缩短羟基脲的建模和提出的分子机制来缩小核糖核苷酸还原酶的作用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: Ribonucleotide Reductase (RNR) is an important anticancer chemotherapy target. It has main key role in DNA synthesis and cell growth. Therefore several RNR inhibitors, such as hydroxyurea, have entered the clinical trials. Based on our proposed mechanism, radical site of RNR protein reacts with hydroxyurea in which hydroxyurea is converted into its oxidized form compound III, and whereby the tyrosyl radical is converted into a normal tyrosine residue.
机译:背景:核糖核苷酸还原酶(RNR)是重要的抗癌靶标。 它具有在DNA合成和细胞生长中的主要关键作用。 因此,几种RNR抑制剂如羟基脲,已进入临床试验。 基于我们所提出的机制,RNR蛋白的根本位点与羟基脲反应,其中羟基脲转化为其氧化形式化合物III,从而将酪晶基团转化为正常酪氨酸残基。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号